Dawaa Dost Revenue and Competitors

Jaipur,

Location

#9036

Growjo Ranking

Pharma

Industry

Estimated Revenue & Valuation

  • Dawaa Dost's estimated annual revenue is currently $39.6M per year.(i)
  • Dawaa Dost's estimated revenue per employee is $242,926

Employee Data

  • Dawaa Dost has 163 Employees.(i)
  • Dawaa Dost grew their employee count by 75% last year.

Dawaa Dost's People

NameTitleEmail/Phone
1
Project Manager - Founder's OfficeReveal Email/Phone
2
Head HRReveal Email/Phone
3
Cluster ManagerReveal Email/Phone
4
Cluster ManagerReveal Email/Phone
5
Product ManagerReveal Email/Phone
6
District ManagerReveal Email/Phone
7
Assistant General ManagerReveal Email/Phone
8
Supply Chain ManagerReveal Email/Phone
9
Digital Sales ManagerReveal Email/Phone
10
Cluster Sales ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$53.7M26716%N/AN/A
#2
$53.1M26421%N/AN/A
#3
$69.1M34426%N/AN/A
#4
$22.1M110-10%N/AN/A
#5
$151.8M75511%N/AN/A
#6
$63.9M31813%N/AN/A
#7
$29.9M14913%N/AN/A
#8
$1.7M17-6%$114.3MN/A
#9
$6.8M34-6%N/AN/A
#10
$12.5M62-9%N/AN/A
Add Company

What Is Dawaa Dost?

We are Jaiur's #1 Affordable Pharmacy !

keywords:N/A

N/A

Total Funding

163

Number of Employees

$39.6M

Revenue (est)

75%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Dawaa Dost News

2022-04-20 - Mobility startup ?Chalo’s turning point YourStory

Mobility startup ?Chalo’s turning point YourStory

2022-04-17 - [Startup Bharat] Dawaa Dost aims to address healthcare problems and reduce expenditure on medicines by 50-80 p YourStory

[Startup Bharat] Dawaa Dost aims to address healthcare problems and reduce expenditure on medicines by 50-80 p YourStory

2022-03-30 - [Funding roundup] CynLr, PlayVerse, CultYvate, Wagr raise early-stage capital YourStory

[Funding roundup] CynLr, PlayVerse, CultYvate, Wagr raise early-stage capital YourStory

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$43.9M16317%N/A
#2
$23.5M1688%N/A
#3
$30.1M1716%N/A
#4
$27.8M17455%N/A
#5
$30.8M175-5%N/A